Cover Image

Diabetic kidney disease—Recent updates

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Zachary Bloomgarden
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of Diabetes
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recent Articles—Skeletal Muscle and Other Topics in Diabetes
by: Zachary Bloomgarden
Published: (2025)

Updates in Type 1 Diabetes ( T1D ): What Recent Findings Might Mean for Treatment and Prevention Strategies
by: Zachary Bloomgarden
Published: (2026)

Cardiovascular Disease, Cancer and Dementia in Diabetes: 20‐Year Trends Will Necessitate New Treatment Priorities
by: Zachary T. Bloomgarden
Published: (2026)

Diabetic Kidney Disease Update
by: Christian Mende, et al.
Published: (2025)

What will we see in diabetes in the next 10 years?
by: Zachary T. Bloomgarden
Published: (2024)

The 2023 WCIRDC: Obesity
by: Zachary T. Bloomgarden
Published: (2024)

Glucagon‐Like Peptide‐1 Receptor Agonists and Anesthesia—Are We Clearer on the Correct Approach?
by: Zachary Bloomgarden
Published: (2024)

What is in a name and other peeves
by: Zachary Bloomgarden
Published: (2024)

Imelda Lee—A memorial note
by: Zachary Bloomgarden
Published: (2024)

Beyond GLP ‐1
by: Zachary Bloomgarden
Published: (2026)

An Update on GLP‐1 Receptor Agonists
by: Zachary Bloomgarden
Published: (2025)

Deciphering the connection: Diabetes, pericyte dysfunction, and their impact on cardiovascular health
by: Robert Chilton, et al.
Published: (2024)

Prevalence of diagnostic Mendelian kidney disease variants in type 2 diabetes with and without diabetic kidney disease
by: Yosuke Hirakawa, et al.
Published: (2026)

Recent updates to understand the heterogeneity of type 2 diabetes mellitus
by: Jianping Weng
Published: (2025)

Diabetic kidney disease, biomarkers, and finerenone
by: Ashish Verma, et al.
Published: (2026)

Nutrient quality in dietary therapy for diabetes and diabetic kidney disease
by: Hiroaki Tsuruta, et al.
Published: (2024)

Social deprivation and diabetic kidney disease: A European view
by: Caoimhe Casey, et al.
Published: (2024)

Pathogenic variants prevalence patients with diabetic kidney disease in Japan: A descriptive study
by: Toyohiro Hashiba, et al.
Published: (2025)

Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity
by: Jae Hyun Bae, et al.
Published: (2024)

Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide
by: Dario Giugliano, et al.
Published: (2024)

Renal effects and safety between Asian and non‐Asian chronic kidney disease and type 2 diabetes treated with nonsteroidal mineralocorticoid antagonists
by: Xiaoming Xu, et al.
Published: (2024)

Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients
by: Yan Wang, et al.
Published: (2024)

Retrospective database study on risk factors for diabetic retinopathy and diabetic kidney disease in Japanese patients with diabetes mellitus
by: Kota Yamada, et al.
Published: (2024)

Remnant cholesterol/high‐density lipoprotein cholesterol ratio is a new powerful tool for identifying diabetic kidney disease
by: Jiale Zhang, et al.
Published: (2026)

An update of contemporary insulin therapy
by: Yuan‐Yu Tsai, et al.
Published: (2024)

Glucagon‐like peptide‐1 receptor agonists and kidney outcomes
by: Richard J. MacIsaac, et al.
Published: (2024)

The health‐economic impact of urine albumin‐to‐creatinine ratio testing for chronic kidney disease in Japanese patients with type 2 diabetes
by: Koichi Asahi, et al.
Published: (2024)

Effectiveness of finerenone in Chinese patients with type 2 diabetes mellitus and chronic kidney disease with microalbuminuria: A retrospective real‐world study
by: Yiming Wu, et al.
Published: (2025)

METTL3/YTHDF3 m6A axis promotes ferroptosis in diabetic kidney disease by stabilizing TfR1
by: Jinmei Zhang, et al.
Published: (2025)

Tracking three decades of type 1 diabetes‐related chronic kidney disease in East Asia: Burden, age–sex patterns, and quality of care index
by: Qiongfang Zhang, et al.
Published: (2026)

Commentary on: Inhibition of LINC00707 / miR ‐223‐3p/ FKBP5 axis has a protective effect on diabetic kidney disease
by: Yirui Zhao, et al.
Published: (2025)

Iron‐Deficiency Anemia Elevates Risk of Diabetic Kidney Disease in Type 2 Diabetes Mellitus
by: Bin Huang, et al.
Published: (2025)

Long‐term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52‐week postmarketing clinical study ( TWINKLE )
by: Tetsuya Babazono, et al.
Published: (2025)

The impact of dynamic kidney function prior to using sodium–glucose cotransporter‐2 inhibitors in type 2 diabetes patients with low‐risk renal disease progression
by: Yen‐Chen Chiu, et al.
Published: (2025)

Correction to “Iron‐Deficiency Anemia Elevates Risk of Diabetic Kidney Disease in Type 2 Diabetes Mellitus”
Published: (2025)

Comment on “The impact of dynamic kidney function prior to using sodium–glucose cotransporter‐2 inhibitors in type 2 diabetes patients with low‐risk renal disease progression”
by: Shyam Sundar Sah, et al.
Published: (2025)

Smoking and diabetic nephropathy: An updated systematic review and meta‐analysis
by: Haihui Zhu, et al.
Published: (2024)

Diabetes Technology Accessibility in Deaf and Hard of Hearing People With Diabetes
by: Michelle L. Litchman, et al.
Published: (2025)

Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease—A practical update for clinicians
by: Jelle M. Beernink, et al.
Published: (2025)

Diabetic Neuropathy Is Related to Rhinencephalon Degeneration in Adults With Type 1 Diabetes
by: Maciej Chudzinski, et al.
Published: (2024)